Cargando…
Identification of Continuous Human B-Cell Epitopes in the Envelope Glycoprotein of Dengue Virus Type 3 (DENV-3)
BACKGROUND: Dengue virus infection is a growing global public health concern in tropical and subtropical regions of the world. Dengue vaccine development has been hampered by concerns that cross-reactive immunological memory elicited by a candidate vaccine could increase the risk of development of m...
Autores principales: | da Silva, Andréa N. M. Rangel, Nascimento, Eduardo J. M., Cordeiro, Marli Tenório, Gil, Laura H. V. G., Abath, Frederico G. C., Montenegro, Silvia M. L., Marques, Ernesto T. A. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2760205/ https://www.ncbi.nlm.nih.gov/pubmed/19826631 http://dx.doi.org/10.1371/journal.pone.0007425 |
Ejemplares similares
-
Correction: Identification of Continuous Human B-Cell Epitopes in the Envelope Glycoprotein of Dengue Virus Type 3 (DENV-3)
por: da Silva, Andréa N. M. Rangel, et al.
Publicado: (2009) -
Identification of Conserved and HLA Promiscuous DENV3 T-Cell Epitopes
por: Nascimento, Eduardo J. M., et al.
Publicado: (2013) -
Computational Prediction and Analysis of Envelop Glycoprotein Epitopes of DENV-2 and DENV-3 Pakistani Isolates: A First Step towards Dengue Vaccine Development
por: Amat-ur-Rasool, Hafsa, et al.
Publicado: (2015) -
HLA-B∗44 Is Associated with Dengue Severity Caused by DENV-3 in a Brazilian Population
por: Xavier Eurico de Alencar, Liciana, et al.
Publicado: (2013) -
A live dengue virus vaccine carrying a chimeric envelope glycoprotein elicits dual DENV2-DENV4 serotype-specific immunity
por: Young, Ellen, et al.
Publicado: (2023)